leisure time -WSS

leisure time

author：Wikipedia 2025-10-02 16:00:46 - browse：77855

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And will there ever be an Apple of pharma?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. In the wake of a massively important clinical trial of Novo Nordisk’s obesity drug Wegovy, our colleague Elaine Chen joins us to explain what we know and don’t know about data that could change the practice of medicine. Then, Mizuho Securities biotech strategist Jared Holz calls in to discuss whether explosive popularity of obesity treatments could help create the first trillion-dollar drug company.

For more on what we cover, here’s the news on the Wegovy study; here’s more on its implications; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Alkermes shareholders re
Next article： Undocumented workers face uncertainty as immigration law takes effect in Florida

leisure time

knowledge

WSS

Undocumented workers face uncertainty as immigration law takes effect in Florida

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

It's time to get medical device identifiers over the finish line

Leqembi, other new Alzheimer’s drugs require better biomarkers

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

New research casts further doubt on a common procedure used with IVF

hotspot

leisure time

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Skip the lead apron during X

Drug repurposing or repositioning? The language matters

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Dobbs anniversary: the lost opportunity of abortion as health care

It's time to get medical device identifiers over the finish line

New air purifier tech could be key to improving indoor air quality

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

State Dept. review finds Biden bears some blame for Afghanistan failures

Beach reads and more: STAT's 2023 summer book list

focus

Why 40% Americans with Parkinson’s don’t see a neurologist

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Security flaws in third

Use doctors trained outside the U.S. to ease the physician shortage

Why 40% Americans with Parkinson’s don’t see a neurologist

The wait for US passports is creating travel purgatory and snarling summer plans

leisure time

knowledge

focus

hotspot